Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00625612
First received: February 12, 2008
Last updated: October 8, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 24, 2011
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):